Literature DB >> 33526564

Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis.

Adwaita R Parab1, Laura-Isobel McCall2,3.   

Abstract

Today, more than a billion people-one-sixth of the world's population-are suffering from neglected tropical diseases. Human African trypanosomiasis, Chagas disease, and leishmaniasis are neglected tropical diseases caused by protozoan parasites belonging to the genera Trypanosoma and Leishmania About half a million people living in tropical and subtropical regions of the world are at risk of contracting one of these three infections. Kinetoplastids have complex life cycles with different morphologies and unique physiological requirements at each life cycle stage. This review covers the latest findings on metabolic pathways impacting disease pathogenesis of kinetoplastids within the mammalian host. Nutrient availability is a key factor shaping in vivo parasite metabolism; thus, kinetoplastids display significant metabolic flexibility. Proteomic and transcriptomic profiles show that intracellular trypanosomatids are able to switch to an energy-efficient metabolism within the mammalian host system. Host metabolic changes can also favor parasite persistence, and contribute to symptom development, in a location-specific fashion. Ultimately, targeted and untargeted metabolomics studies have been a valuable approach to elucidate the specific biochemical pathways affected by infection within the host, leading to translational drug development and diagnostic insights.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  Chagas disease; Leishmania; Trypanosoma; Trypanosoma brucei; Trypanosoma cruzi; disease pathogenesis; host-parasite interactions; kinetoplastids; leishmaniasis; metabolism; neglected tropical diseases; sleeping sickness

Year:  2021        PMID: 33526564      PMCID: PMC8090971          DOI: 10.1128/IAI.00644-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  139 in total

1.  An in silico approach in identification of drug targets in Leishmania: A subtractive genomic and metabolic simulation analysis.

Authors:  Rohan J Meshram; Mayuri B Goundge; Baban S Kolte; Rajesh N Gacche
Journal:  Parasitol Int       Date:  2018-11-29       Impact factor: 2.230

2.  Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo.

Authors:  Pascale Kropf; José M Fuentes; Eva Fähnrich; Luis Arpa; Shanthi Herath; Verena Weber; Germán Soler; Antonio Celada; Manuel Modolell; Ingrid Müller
Journal:  FASEB J       Date:  2005-04-05       Impact factor: 5.191

3.  Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients.

Authors:  Jian-jun Wen; Pedro C Yachelini; Adela Sembaj; Rafael E Manzur; Nisha Jain Garg
Journal:  Free Radic Biol Med       Date:  2006-04-26       Impact factor: 7.376

4.  Proline metabolism in procyclic Trypanosoma brucei is down-regulated in the presence of glucose.

Authors:  Nadia Lamour; Loïc Rivière; Virginie Coustou; Graham H Coombs; Michael P Barrett; Frédéric Bringaud
Journal:  J Biol Chem       Date:  2005-01-21       Impact factor: 5.157

5.  A defined medium for Leishmania culture allows definition of essential amino acids.

Authors:  Archana Nayak; Snezhana Akpunarlieva; Michael Barrett; Richard Burchmore
Journal:  Exp Parasitol       Date:  2018-01-08       Impact factor: 2.011

6.  A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity.

Authors:  Elizabeth R Sharlow; Todd A Lyda; Heidi C Dodson; Gabriela Mustata; Meredith T Morris; Stephanie S Leimgruber; Kuo-Hsiung Lee; Yoshiki Kashiwada; David Close; John S Lazo; James C Morris
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

7.  Mass Spectrometry-Based Chemical Cartography of a Cardiac Parasitic Infection.

Authors:  Laura-Isobel McCall; James T Morton; Jean A Bernatchez; Jair Lage de Siqueira-Neto; Rob Knight; Pieter C Dorrestein; James H McKerrow
Journal:  Anal Chem       Date:  2017-09-22       Impact factor: 6.986

8.  Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice.

Authors:  Suraj P Parihar; Mary-Anne Hartley; Ramona Hurdayal; Reto Guler; Frank Brombacher
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 9.  Leishmaniasis: a review.

Authors:  Edoardo Torres-Guerrero; Marco Romano Quintanilla-Cedillo; Julieta Ruiz-Esmenjaud; Roberto Arenas
Journal:  F1000Res       Date:  2017-05-26

10.  Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure.

Authors:  Fernando J Sánchez-Valdéz; Angel Padilla; Wei Wang; Dylan Orr; Rick L Tarleton
Journal:  Elife       Date:  2018-03-26       Impact factor: 8.140

View more
  3 in total

1.  Chemical Cartography Approaches to Study Trypanosomatid Infection.

Authors:  Danya A Dean; Jacob J Haffner; Mitchelle Katemauswa; Laura-Isobel McCall
Journal:  J Vis Exp       Date:  2022-01-21       Impact factor: 1.355

Review 2.  Metabolic flexibility in Trypanosoma cruzi amastigotes: implications for persistence and drug sensitivity.

Authors:  Peter C Dumoulin; Barbara A Burleigh
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

3.  Decreased glutamate transport in acivicin resistant Leishmania tarentolae.

Authors:  Gaétan Roy; Arijit Bhattacharya; Philippe Leprohon; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2021-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.